Bright Minds
DRUG
Bright Minds (DRUG) earnings history
Most recent quarter
- Fiscal period
- Q3 2025
- Period end
- Jun 30, 2025
- EPS actual
- −$0.54
- EPS estimate
- −$0.58
- EPS surprise
- +6.81%
- Revenue surprise
- +0.00%
- Revenue
- $0.00
- Revenue estimate
- $0.00
- Reported
- Aug 15, 2025
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q3 2025 | Aug 15, 2025 | −$0.58 | −$0.54 | +6.81% | $0.00 | SEC |
| Q2 2025 | Aug 11, 2025 | −$0.30 | −$0.29 | +3.15% | $0.00 | SEC |
| Q1 2025 | Feb 14, 2025 | −$0.02 | $0.01 | +144.23% | $0.00 | SEC |
| Q4 2024 | Dec 31, 2024 | −$0.44 | −$0.13 | +71.67% | $0.00 | SEC |
| Q3 2022 | Aug 15, 2022 | $0.00 | −$0.85 | +0.00% | $0.00 | — |
| Q2 2022 | May 16, 2022 | $0.00 | −$1.52 | +0.00% | $0.00 | — |
Quarterly revenue
Frequently asked questions
When did Bright Minds (DRUG) last report earnings?
Bright Minds last reported on Aug 15, 2025, covering fiscal Q3 2025.
Did DRUG beat earnings estimates?
Yes. Bright Minds reported EPS of −$0.54 for Q3 2025 against a −$0.58 estimate — a 6.81% beat.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.